Organic acids - Standard 1 analysis of silylated organic acids in urine

Importance of the topic

Accurate profiling of organic acids in urine is critical for diagnosing inherited metabolic disorders and monitoring physiological changes at the metabolic level. Organic acid analysis provides insights into mitochondrial dysfunction, organic acidurias, and other metabolic conditions, enabling timely clinical interventions and research discoveries.

Objectives and Study Overview

This study describes an optimized GC-MS method for separating and detecting 37 silylated organic acids in human urine within a single 70-minute run. The aim is to demonstrate sample preparation, chromatographic separation, and mass spectrometric detection strategies to achieve reliable identification and quantification of key metabolites.

Methodology

Sample preparation involves spiking 2 mL urine with internal standards (heptanoylglycine and tropic acid) and acidification with 6 N HCl. The mixture is extracted twice with 4 mL ethyl acetate containing n-C23 and n-C24. After centrifugation, the organic phase is dried over sodium sulfate, evaporated to near dryness, and reconstituted in 0.5 mL toluene. Derivatization is performed by adding 200 µL of a silylation reagent (BSTFA, pyridine, and TMCS) at 60 °C for 30 minutes. The reaction is quenched with 0.5 mL hexane before analysis.

Instrumentation Used

• Gas chromatograph with split injector at 270 °C
• Agilent CP-Sil 8 CB Low Bleed/MS capillary column (0.25 mm × 30 m, 0.25 µm film thickness)
• Helium carrier gas at 80 kPa
• Temperature program: 50 °C (1 min) → 80 °C at 10 °C/min → 150 °C at 1.7 °C/min → 220 °C at 3.5 °C/min → 290 °C at 20 °C/min, hold 10 min
• Mass spectrometer detector with source at 270 °C and quadrupole at 220 °C
• Sample injection volume: 1 µL (split)

Main Results and Discussion

The method achieves baseline separation of 37 silylated organic acids within 70 minutes. Target analytes, including lactic, pyruvic, citric, and gamma-hydroxybutyric acids, are identified by their characteristic retention times and mass spectra. The procedure delivers consistent recoveries and detection limits of 2–10 ng per component. The optimized temperature program and column choice minimize bleed and improve peak shape across a wide polarity range.

Benefits and Practical Applications

• Comprehensive coverage of small and medium-chain organic acids in a single analysis
• High sensitivity for trace-level metabolites using silylation and MS detection
• Robust sample prep suitable for routine clinical and research laboratories
• Reproducible retention times facilitating reliable compound identification
• Potential for adaptation to high-throughput screening workflows

Future Trends and Potential Applications

Advances in automated sample preparation and derivatization can increase throughput and reduce variability. Integration with tandem mass spectrometry and high-resolution instruments will enhance specificity and quantitative performance. Coupling organic acid profiling with other omics data sets and machine learning tools offers deeper insights into metabolic diseases and personalized medicine.

Conclusion

The presented GC-MS approach enables efficient and sensitive analysis of a broad spectrum of urinary organic acids. Its combination of streamlined sample preparation, optimized chromatographic separation, and reliable MS detection positions it as a valuable tool for clinical diagnostics and metabolomic research.

References

No additional literature references were provided beyond the original Agilent application note (A01420, October 2011).